Searched for
COMPULSORY LICENCE
Explained: Cost of living in New Zealand and how to plan your expensesNew Zealand has revealed the cost of living for newcomers. Key expenses include housing, which varies by city and type. Food costs depend o...
View: The vaccine patent waiver waversAs per the original 2020 text of the TRIPs waiver proposal, India and South Africa wanted the right to suspend intellectual property (IP) p...
Government in no rush to grant 'compulsory licences'Amid suggestions to use the tool for Remdisivir and Tocilizumab, two drugs that are being used, government sources said that it made little...
Maharashtra seeks compulsory licence for RemdesivirCompulsory licensing (CL) allows the central government to revoke a patent and give other manufacturers permission to produce a drug under ...
Bayer gets over compulsory licence“India is a large market and we will get through the challenges that are there. It is never easy but we also see huge potential in the Indi...
Government won't dilute stance to waive patent rightsThe government has ruled out any dilution in its stance on granting compulsory licences, or waiving patent rights in case of a public healt...
India has right to grant compulsory licences under WTO: GovernmentThe government today said every member of the WTO, including India, has the right to grant compulsory licences (CL) and also decide the gro...
Cancer drug may lose patent shieldA compulsory licence (CL) will allow the government to source generic versions of the patented drug and sell them at a fraction of the cost.
Government rejects BDR Pharma's CL application for anti-cancer drugUnder the Indian Patents Act, if a medicine is deemed unaffordable, a compulsory licence can be issued to a generic drug maker in public in...
BDR Pharma seeks cancer drug licenceBDR Pharma has filed an application with the Mumbai Patent Office, seeking compulsory licence to market a crucial cancer drug, dasatinib
New compulsory licences policy raises monopoly concernsThe Department of Pharmaceutical floated the draft policy on price negotiations for patented drugs in an attempt to regulate the highly-pri...
- Intellectual Property Appellate Board postpones Bayer's compulsory licence appeal
IPAB has postponed German company Bayer AG's appeal against the grant of a compulsory licence of its patented drug Nexavar to Natco Pharma ...
- No applications pending from pharmaceutical companies seeking compulsory licenses: Government
The government has clarified that no applications are pending from pharmaceutical companies seeking compulsory licences for producing low-c...
Natco victory could encourage other generic companies also to apply for compulsory licenceEarlier this week, a ruling effectively cut the price of high-cost cancer drug Sorafenib by 97%. But that’s just one of many legal battles ...
- Natco Pharma files India's first compulsory licence plea
Natco Pharma has applied for the country's first compulsory licence to sell a generic version of Bayer's patented medicine.
- No additional norms to issue compulsory drug licences
The government has decided to retain the flexibility it has in issuing compulsory licences for patented drugs in case of public health emer...
- ET in the classroom: Compulsory licencing
ET explains Compulsory Licensing, a provision that allows governments to override Patent rights